Biosignatures has the capability to reliably discover multiple protein based disease diagnostics.
biosignatures has raised €4.0M across 1 funding round from 1 investor, most recently a round in Oct 2019. Based in Newcastle upon Tyne, UK; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-10-01 | Other | €4.0M |
| ADV |
| View deal → |
